Literature DB >> 21976504

MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34.

Sharon Haramati1, Inbal Navon, Orna Issler, Gili Ezra-Nevo, Shosh Gil, Raaya Zwang, Eran Hornstein, Alon Chen.   

Abstract

The etiology and pathophysiology of anxiety and mood disorders is linked to inappropriate regulation of the central stress response. To determine whether microRNAs have a functional role in the regulation of the stress response, we inactivated microRNA processing by a lentiviral-induced local ablation of the Dicer gene in the central amygdala (CeA) of adult mice. CeA Dicer ablation induced a robust increase in anxiety-like behavior, whereas manipulated neurons survive and appear to exhibit normal gross morphology in the time period examined. We also observed that acute stress in wild-type mice induced a differential expression profile of microRNAs in the amygdala. Bioinformatic analysis identified putative gene targets for these stress-responsive microRNAs, some of which are known to be associated with stress. One of the prominent stress-induced microRNAs found in this screen, miR-34c, was further confirmed to be upregulated after acute and chronic stressful challenge and downregulated in Dicer ablated cells. Lentivirally mediated overexpression of miR34c specifically within the adult CeA induced anxiolytic behavior after challenge. Of particular interest, one of the miR-34c targets is the stress-related corticotropin releasing factor receptor type 1 (CRFR1) mRNA, regulated via a single evolutionary conserved seed complementary site on its 3' UTR. Additional in vitro studies demonstrated that miR-34c reduces the responsiveness of cells to CRF in neuronal cells endogenously expressing CRFR1. Our results suggest a physiological role for microRNAs in regulating the central stress response and position them as potential targets for treatment of stress-related disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21976504      PMCID: PMC6623664          DOI: 10.1523/JNEUROSCI.1673-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  86 in total

1.  Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness.

Authors:  Michael D Conkright; Ernesto Guzmán; Lawrence Flechner; Andrew I Su; John B Hogenesch; Marc Montminy
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

Review 2.  A role for corticotropin releasing factor and urocortin in behavioral responses to stressors.

Authors:  G F Koob; S C Heinrichs
Journal:  Brain Res       Date:  1999-11-27       Impact factor: 3.252

3.  Delivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo.

Authors:  A Pfeifer; E P Brandon; N Kootstra; F H Gage; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

Review 4.  The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety.

Authors:  F Holsboer
Journal:  J Psychiatr Res       Date:  1999 May-Jun       Impact factor: 4.791

5.  Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids.

Authors:  Alon Chen; Marilyn Perrin; Bhawanjit Brar; Chien Li; Pauline Jamieson; Mike Digruccio; Kathy Lewis; Wylie Vale
Journal:  Mol Endocrinol       Date:  2004-10-28

6.  Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress.

Authors:  Marianne B Müller; Stephan Zimmermann; Inge Sillaber; Thomas P Hagemeyer; Jan M Deussing; Peter Timpl; Michael S D Kormann; Susanne K Droste; Ralf Kühn; Johannes M H M Reul; Florian Holsboer; Wolfgang Wurst
Journal:  Nat Neurosci       Date:  2003-09-14       Impact factor: 24.884

7.  Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.

Authors:  Eric P Zorrilla; Lindsay E Reinhardt; Glenn R Valdez; Koki Inoue; Jean E Rivier; Wylie W Vale; George F Koob
Journal:  J Pharmacol Exp Ther       Date:  2004-04-28       Impact factor: 4.030

Review 8.  Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders.

Authors:  Andrew Holmes; Markus Heilig; Nadia M J Rupniak; Thomas Steckler; Guy Griebel
Journal:  Trends Pharmacol Sci       Date:  2003-11       Impact factor: 14.819

Review 9.  Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation.

Authors:  Stephen C Heinrichs; George F Koob
Journal:  J Pharmacol Exp Ther       Date:  2004-08-05       Impact factor: 4.030

10.  Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus.

Authors:  S Srinivas; T Watanabe; C S Lin; C M William; Y Tanabe; T M Jessell; F Costantini
Journal:  BMC Dev Biol       Date:  2001-03-27       Impact factor: 1.978

View more
  101 in total

Review 1.  Integrated circuits and molecular components for stress and feeding: implications for eating disorders.

Authors:  J A Hardaway; N A Crowley; C M Bulik; T L Kash
Journal:  Genes Brain Behav       Date:  2015-01       Impact factor: 3.449

2.  A placental mammal-specific microRNA cluster acts as a natural brake for sociability in mice.

Authors:  Martin Lackinger; A Özge Sungur; Reetu Daswani; Michael Soutschek; Silvia Bicker; Lea Stemmler; Tatjana Wüst; Roberto Fiore; Christoph Dieterich; Rainer Kw Schwarting; Markus Wöhr; Gerhard Schratt
Journal:  EMBO Rep       Date:  2018-12-14       Impact factor: 8.807

3.  MicroRNA-34a Regulates the Depression-like Behavior in Mice by Modulating the Expression of Target Genes in the Dorsal Raphè.

Authors:  Luisa Lo Iacono; Donald Ielpo; Alessandra Accoto; Matteo Di Segni; Lucy Babicola; Sebastian Luca D'Addario; Fabio Ferlazzo; Tiziana Pascucci; Rossella Ventura; Diego Andolina
Journal:  Mol Neurobiol       Date:  2019-09-03       Impact factor: 5.590

4.  Hypoxia induces downregulation of soluble guanylyl cyclase β1 by miR-34c-5p.

Authors:  Xiaojian Xu; Shumin Wang; Juan Liu; Dou Dou; Limei Liu; Zhengju Chen; Liping Ye; Huixia Liu; Qiong He; J Usha Raj; Yuansheng Gao
Journal:  J Cell Sci       Date:  2012-10-04       Impact factor: 5.285

Review 5.  The Role of MicroRNAs in Environmental Risk Factors, Noise-Induced Hearing Loss, and Mental Stress.

Authors:  Verónica Miguel; Julia Yue Cui; Lidia Daimiel; Cristina Espinosa-Díez; Carlos Fernández-Hernando; Terrance J Kavanagh; Santiago Lamas
Journal:  Antioxid Redox Signal       Date:  2017-06-30       Impact factor: 8.401

6.  Whiplash-Associated Dysphagia: Considerations of Potential Incidence and Mechanisms.

Authors:  D Stone; H Bogaardt; S D Linnstaedt; B Martin-Harris; A C Smith; D M Walton; E Ward; J M Elliott
Journal:  Dysphagia       Date:  2019-08-03       Impact factor: 3.438

7.  The microRNA network is altered in anterior cingulate cortex of patients with unipolar and bipolar depression.

Authors:  Joshua A Azevedo; Bradley S Carter; Fan Meng; David L Turner; Manhong Dai; Alan F Schatzberg; Jack D Barchas; Edward G Jones; William E Bunney; Richard M Myers; Huda Akil; Stanley J Watson; Robert C Thompson
Journal:  J Psychiatr Res       Date:  2016-07-18       Impact factor: 4.791

Review 8.  MicroRNA's impact on neurotransmitter and neuropeptide systems: small but mighty mediators of anxiety.

Authors:  Stefanie Martinetz
Journal:  Pflugers Arch       Date:  2016-04-30       Impact factor: 3.657

Review 9.  Translational approaches to anxiety: focus on genetics, fear extinction and brain imaging.

Authors:  Angelika Erhardt; Victor I Spoormaker
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

10.  Increased miR-132-3p expression is associated with chronic neuropathic pain.

Authors:  M Leinders; N Üçeyler; R A Pritchard; C Sommer; L S Sorkin
Journal:  Exp Neurol       Date:  2016-06-24       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.